2-[(4-ethoxyphenyl)sulfonylamino]-5-[4-(2-fluorophenyl)piperazin-1-yl]benzoic acid;2,2,2-trifluoroacetic acid
C27H27F4N3O7S — CID 146057835
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(4-ethoxyphenyl)sulfonylamino]-5-[4-(2-fluorophenyl)piperazin-1-yl]benzoic acid;2,2,2-trifluoroacetic acid
2-[(4-ethoxyphenyl)sulfonylamino]-5-[4-(2-fluorophenyl)piperazin-1-yl]benzoic acid;2,2,2-trifluoroacetic acid (PubChem CID 146057835) has the molecular formula C27H27F4N3O7S and a molecular weight of 613.59 g/mol. Its IUPAC name is 2-[(4-ethoxyphenyl)sulfonylamino]-5-[4-(2-fluorophenyl)piperazin-1-yl]benzoic acid;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | 2-[(4-ethoxyphenyl)sulfonylamino]-5-[4-(2-fluorophenyl)piperazin-1-yl]benzoic acid;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 146057835 |
| Molecular Formula | C27H27F4N3O7S |
| Molecular Weight | 613.59 g/mol |
| Exact Mass | 613.15 |
| IUPAC Name | 2-[(4-ethoxyphenyl)sulfonylamino]-5-[4-(2-fluorophenyl)piperazin-1-yl]benzoic acid;2,2,2-trifluoroacetic acid |
| SMILES | CCOc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4ccccc4F)CC3)cc2C(=O)O)cc1.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C25H26FN3O5S.C2HF3O2/c1-2-34-19-8-10-20(11-9-19)35(32,33)27-23-12-7-18(17-21(23)25(30)31)28-13-15-29(16-14-28)24-6-4-3-5-22(24)26;3-2(4,5)1(6)7/h3-12,17,27H,2,13-16H2,1H3,(H,30,31);(H,6,7) |
| InChIKey | DVKLJLNCZUMBGO-UHFFFAOYSA-N |
| XLogP | 4.68 |
| TPSA | 136.48 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 613.59 |
| LogP ≤ 5 | 4.68 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146057835 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.